Redcliffe Labs Expands National Footprint with Strategic Entry into Imphal

2026-07-09 02:45:06 Business

223

Imphal, Manipur, 09 July 2026: Redcliffe Labs, one of India's fastest-growing omnichannel diagnostic service providers, has announced the launch of its first state-of-the-art diagnostic laboratory in Imphal, marking the company's entry into Manipur and further strengthening its commitment to expanding quality healthcare infrastructure across underserved regions of the country.

With this expansion, Redcliffe Labs becomes one of the first three national diagnostic brands to establish a laboratory footprint in the state, bringing reliable, affordable, and high-quality diagnostic services closer to communities across Manipur. Located at RIMS Road, Lalambung Makhong, Thangmeiband, the new facility aims to improve access to advanced diagnostics and reduce reliance on sending samples outside the region for testing.

While healthcare infrastructure continues to evolve across the country, access to advanced diagnostic services remains a challenge in several regions, particularly in remote and geographically complex terrains. By establishing a presence in Imphal, Redcliffe Labs aims to strengthen diagnostic access in the region. Every test comes with 4X value benefits, including doctor-verified Smart Reports, expert consultation, personalized diet consultation, and 24x7 AI assistance, enabling individuals to make more informed health decisions with actionable insights along with a digital-first healthcare ecosystem.

The state-of-the-art laboratory will offer a comprehensive range of pathology services across Biochemistry, Hematology, Immunoassays, Clinical Pathology, Serology, Hormone, and Microbiology testing, including automated cultures. Patients can conveniently access these services through both laboratory walk-ins and home sample collection, ensuring greater comfort and flexibility, especially for elderly individuals, patients with mobility constraints, and working professionals. Beyond pathology services, patients will also have access to a wider range of diagnostic services through Redcliffe Labs' collaboration with Padma Diagnostic Center. These include X-Ray, Ultrasound, Portable ECG with tele-reporting, EEG, Spirometry, 24-hour, 48-hour and 72-hour Holter ECG monitoring, and DEXA Scan services.

The laboratory operations will be led by Dr. Th. Jyotamala Devi, MD Pathologist, and supported by a team of experienced professionals following standardized processes aligned with NABL and ISO guidelines. The facility will cater to residents across Thangmeiband, Keishampat, Sagolband, Naoremthong, Majorkhul, Tera, Dewlahland, Uripok, Lalambung Makhong, Lamphelpat, Langol, Singjamei, Chingamakha, Kshetrigao, Thongju, Wangkhei, Porompat, Kongba, Khurai, Chingmeirong, Heingang, Canchipur, Ghari, Samurou, and neighboring regions.

Commenting on the launch, Aditya Kandoi, Founder & CEO, Redcliffe Labs, said, "Building healthcare infrastructure in geographically complex regions requires long-term commitment and strong local partnerships. The Northeast presents unique accessibility challenges, making reliable diagnostics critical to timely healthcare decisions. Our presence in Imphal is an important step towards strengthening diagnostic capabilities in the region and ensuring that quality testing is available when it matters the most."

Dr. Sonal Saxena, Medical Director, Redcliffe Labs, added, "Every clinical decision begins with a diagnostic result, making accuracy and reliability fundamental to quality healthcare. At Redcliffe Labs, we follow stringent quality protocols, standardized processes, and robust quality control measures to ensure every report meets the highest standards of precision. Our laboratory in Imphal will bring the same commitment to diagnostic excellence that patients and healthcare professionals across the country have come to trust."

The Imphal laboratory reflects Redcliffe Labs' continued focus on expanding access to quality diagnostics in underserved regions of the country, reinforcing its commitment to building a more accessible and equitable healthcare ecosystem for Bharat.

About Redcliffe Labs:

Redcliffe Labs is an impact-driven, fastest-growing diagnostic healthcare network redefining healthcare access across India to add Healthy Years to Lives. Having served over 1 crore customers to date, the company operates with a preventive-first approach across 220+ cities through 80+ owned advanced laboratories and coverage of 4,000+ pincodes, offering 3,600+ diagnostic tests powered by clinical expertise and AI-led innovation. With convenient home sample collection, smart health insights, and personalized wellness solutions, Redcliffe Labs offers a complete care plan that delivers 4X benefits with every test, enabling earlier risk detection and better health every day.